Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot-Reference-Cited by-同舟云学术

Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot

Published:2018-10 Issue:10 Volume:30 Page:1237-1246
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Abdel-Razik Ahmed,Mousa Nasser,Shabana Walaa,Refaey Mohamed,Elzehery Rasha,Elhelaly Rania,Zalata Khaled,Abdelsalam Mostafa,Eldeeb Ahmed A.,Awad Mahmoud,Elgamal Ayman,Attia Ahmed,El-Wakeel Niveen,Eldars Waleed

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference42 articles.

1. Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review;Arab;World J Gastroenterol,2014

2. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome;Lonardo;Dig Liver Dis,2015

3. Non-alcoholic fatty liver disease: what the clinician needs to know;Machado;World J Gastroenterol,2014

4. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012

5. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis;Tilg;Hepatology,2010

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ammonia-induced stress response in liver disease progression and hepatic encephalopathy;Nature Reviews Gastroenterology & Hepatology;2024-09-09

2. Therapeutic potential of rifaximin in liver diseases;Biomedicine & Pharmacotherapy;2024-09

3. Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges;Engineering;2024-09

4. Current strategies for nonalcoholic fatty liver disease treatment (Review);International Journal of Molecular Medicine;2024-08-08

5. Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment;Hepatology Communications;2024-07